What is Prozac? A debate between science and society perspective, during SARS-COV2
Keywords:
antidepresivo, depresión, enfermedad, vida, complicaciones fisiológicasAbstract
This study will test the efficacy of Prozac in patients that think were sick with COVID-19 virus or any other serious respiration condition is not fun. The SARS-COV2 had and has dramatic effects. This investigation was necessary to prevent serious outcomes, especially suicide. It is a strategy to prevent COVID-19 infection specially. Many people thought that had COVID 19. Patients who are presumptively depression for COVID-19 will be entered into the study and given the option to start the medication Prozac. The testimonies of patients who were treated with Prozac were used after developing a clinical picture of stress, anxiety and depression as a consequence of the confinement of the pandemic.The case will be monitored daily for COVID-19 symptoms and weekly for side effects and tolerance of Prozac. The testimony, in this case, expressed through a first-person interview, offered not only information regarding the perceptions, ideas and meanings of patients prescribed Prozac; but also expressed meanings beyond words. For example: the type of posture, the reactions, sadness, happiness, the same meaning that they gave to their life. The subjects were vicivilized by means of this technique and autonomy, self-confidence, desire to live were fostered.
Keywords: Antidepressant, depression, illness, life, physiological complications.
Downloads
References
Baldin, E., Cotelli, P., & Guarino, M. (2020). Risk of Hospitalization and Death for COVID‐19 in People With Parkinson's Disease or Parkinsonism. Wiley Public Health Emergency Collection, 1-20.
Healy, D. (2012). Reseña de Let them eat Prozac. The unhealthy relationship between the pharmaceutical industry and depression, de David Healy. Neuropsiquiatría, 1-10.
Johnson, B., & Christensen, L. (2014). Educational Research Quantitative, Qualitative,and Mixed Approaches. Los Angeles: SAGE.
Kuntz, J. (2019). Resilience in times of global pandemic: Steering recovery and thriving trajectories. Wlley Public Health Emergency COVID-19 Initiative.
Maximilians, J. (2019). Antidepressant inhibits coronavirus. Healthcare-in-europe.
Mccullumsmith, C. (2020). COVID-19 is an emerging, rapidly evolving situation. Clinical Trials.gov.
Molla, M., Sohel, A., & Shutter, M. (2020). Fluoxetine. Bookshelf, 1-10.
Oyarzabal, B. (2007). Estrés social y estrés medio crónico: cambios conductuales, neuroendocrinos e inmunitario.
Pathak, V., Jena, B., & Sanjay, K. (2013). Qualitative research. Perspectives in Clinical Research, 4, 192-202.
Pérez, V., Speranza, N., & Tamosiunas, G. (2016). Perfil de riesgo de los antidepresivos inhibidores selectivos de la recaptación de serotonina (ISRS). Revisión(3), 25-33
Riessman, C. (2008). Narrative Methods for the Human Sciences. California: Priented in the United States of America.
Rosenteins, S. (2011). Diccionario de Especialidades Farmacéuticas 2011. 37. Quito, Ecuador: PLM.
Soto, P., & Villareal, R. (2015). Some specificities regarding the suicidal behavior. MEDISAN, 1-19.
Word Heald, O. (2007). Drug and Therapeutics Committee Training Course.Committee—Overview. Session 1. Drug and Therapeutics. U.S.: USAID.
